OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests
OPKO Health announced the issuance of $125 million in senior secured notes backed by their royalty rights from the mazdutide license agreement with Eli Lilly, thereby expanding their financial relationship with HealthCare Royalty (a KKR business). This transaction provides OPKO with additional non-dilutive capital, preserving long-term participatio…